iCureCeliac® Studies

A study led by Columbia University and Celiac Disease Foundation researchers examined probiotic use among celiac disease patients and was an Outstanding Poster Presenter recipient at the 2020 ACG Annual Scientific Meeting.

The following study, which examines the prevalence of dermatitis herpetiformis (DH), was made possible by the Foundation’s iCureCeliac® patient registry.

CEO Marilyn G. Geller speaks at the 18th International Celiac Disease Symposium (ICDS).

At the Digestive Disease Week meeting in San Diego, researchers from Takeda and the Celiac Disease Foundation presented a study entitled, Adherence to the gluten-free diet and celiac patients outcomes: real world evidences from an international patient registry, iCureCeliac®. 

Researchers analyzed iCureCeliac® patient registry data to determine the effect of celiac disease-related depression on patients’ symptomatic response to a gluten-free diet.